Rescue medication use in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in England

Conclusions: Newly prescribed UMEC/VI was superior to TIO/OLO on rescue medication use in patients with COPD in England.Funding: GSK (study 217815)

Source: European Respiratory Journal - December 1, 2022 Category: Respiratory Medicine Authors: Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C., Yeap, J., Wild, R., Compton, C., Duarte, M., Rothnie, K., Ismaila, A. Tags: 05.01 - Airway pharmacology and treatment Source Type: research